期刊文献+

急性心肌梗死合并心源性休克经皮冠状动脉介入治疗术后死亡的风险因素分析 被引量:8

Risk factors for death after percutaneous coronary intervention in patients of acute myocardial infarction combined with cardiogenic shock
下载PDF
导出
摘要 目的分析急性心肌梗死(AMI)合并心源性休克(CS)患者经皮冠状动脉介入治疗(PCI)术后死亡的风险因素。方法回顾性分析46例接受了PCI治疗的AMI患者(男35例,女11例,年龄42~95岁,存活出院27例,院内死亡19例)的临床资料,应用多因素Logistic回归模型分析与AMI合并cS患者PCI术后死亡相关的风险因素。结果死亡组年龄(74.37±10.26)岁,显著长于存活组[(62.96±10.40)岁](P〈0.05);死亡组中有心肌梗死史者,并发糖尿病及高血压者的比例均显著高于存活组(均P〈0.05)。死亡组血肌酐(Cr)峰值为(137.74±52.40)μmmol/L,显著高于存活组【(94.48±25.18)μmmol/L],死亡组左室射血分数(EF)为(31.05±8.43)%,显著低于存活组[(38.93±8.40)%](均P〈0.05)。结论年龄≥65岁、陈旧性心肌梗死、糖尿病、高血压、EF〈35%、肾功能不全(Cr〉133μmol/L)是AMI合并CS患者PCI术后死亡的相关风险因素。 Objective To investigate the risk factors for death after percutaneous coronary intervention (PCI) in patients of acute myocardial infarction (AMI) combined with eardiogenic shock (CS). Methods The clinical data of 46 patients of AMI combined with CS undergoing PCI, 35 males and 11 females, aged 42-95, of which 27 survived and were discharged from hospital and 19 died in hospital, were analyzed. Multivariate Logistic regression model was used to analyze the risk factors for death after PCI. Results The age of the death group was (74.37±10.26) years, significantly elder than that of the survival group [(62.96 ±10.40) years, P〈 0.05]. The proportions of those with cardiac infarction history, diabetes, and hypertension in the death group were all significantly higher than those in the survival group (all P〈0.05). The peak serum ereatinine (Cr) level of the death group was (137.74±52.40) μmmol/L, significantly higher than that of the survival group [(94.48±25.18) μmmol/L, P〈0.05]. The left ventricular ejection fraction (EF) of the death group was (31.05±8.43)%, signifieandy lower than that of the survival group [(38.93±8.40)%, /9〈0.05]. Conclusion Age〉≥65 years, previous myocardial infarction, diabetes, hypertension, EF 〈 35%, and renal insufficiency (Cr 〉 133 μmol/L) are the risk factors for death after PCI in the patients of AMI combined with CS.
作者 郭卿 李东霞
出处 《中国急救复苏与灾害医学杂志》 2011年第9期746-748,751,共4页 China Journal of Emergency Resuscitation and Disaster Medicine
关键词 急性心肌梗死 心源性休克 介入治疗 院内死亡 Acute myocardial infarction, Cardiogenic shock, Percutaneous coronary intervention, In-hospital mortality
  • 相关文献

参考文献15

  • 1Fox KA,Anderson FA Jr,Dabbous OH,et al.Intervention in acute coronary syndromes:do patients undergo intervention on the basis of their risk characteristics? The Global Registry of Acute Coronary Events(GRACE).Heart,2007,93(2):177-182.
  • 2Babaev A,Frederick PD,Pasta DJ,et al.Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock.JAMA,2005,294(4):448-454.
  • 3Hochman JS,Sleeper LA,Webb JG,et al.Early revascularization in acute myocardial infarction complicated by cardiogenic shock.N Engl J Med,1999,341(9):625-634.
  • 4Hochman JS,Buller CE,Sleeper LA,et al.Cardiogenic shock complicating acute myocardial infarction--etiologies,management and outcome:a report from the SHOCK Trial Registry.Should we emergently revascularize occluded coronaries for cardiogenic shock? J Am Coll Cardiol,2000,36(3Suppl A):1063-1070.
  • 5Alpert JS,Thygesen K,Antman E,et al.Myocardial infarction redefined-a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction.J Am Coll Cardiol,2000,36(3):959-969.
  • 6Reynolds HR,Hochman JS.Cardiogenic shock:current concepts and improving outcomes.Circulation,2008,117(5):686-697.
  • 7Iakobishvili Z,Behar S,Boyko V,et al.Does current treatment of cardiogenic shock complicating the acute coronary syndromes comply with guidelines?Am Heart J,2005,149(1):98-103.
  • 8Theroux P,Armstrong PW,Mahaffey KW,et al.Prognostic significance of blood markers of inflammation in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty and effects of pexelizumab,a C5 inhibitor:a substudy of the COMMA trial.Eur Heart J,2005,26(19):1964-1970.
  • 9Dzavik V,Cotter G,Reynolds HR,et al.Effect of nitric oxide synthase inhibition on haemodynamics and outcome of patients with persistent cardiogenic shock complicating acute myocardial infarction:a phase II dose-ranging study.Eur Heart J,2007,28(9):1109-1116.
  • 10Valente S,Lazzeri C,Giglioli C,et al.Contrast-induced nephropathy in urgent coronary interventions.J Cardiovasc Med (Hagerstown),2006,7(10):737-741.

二级参考文献8

  • 1[1]Anman EM,Braunwald E.In:Braunwald E,et al.Heart disease-a textbook of Cardiovascular Medicine.5th,Harcourt Asia:WB Saunders Company,1997,1238-1240.
  • 2[3]Mehlhom U,Kroner A,de givie ER.30 years clinical intra,aortic balloon pumping:facts and figures.Thorac Cardiovase Surg,1999,47(supple 2):298.
  • 3[4]Barron HV,Every NR,Parsons LS,et al.The use of intraaortic balloon counterpulsation in patients with cardiogenic shock complicating acute myocardial infarction:data from the National Registry of Myocardial Infarction.Am Heart,2001,141(6):933.
  • 4[6]Hochman JS,Sleeper LA,White HD,et al.One year survival following early revascularizat ion for cardiogenic shock.JAMA,2001,285 (2):190-192.
  • 5[10]Meco M,Gramegna G.Mortality and morbidity from intra-aortic balloon pumps.Risk analysis.Cardiovasc Surg (Torino),2002,43(1):17.
  • 6[11]Wang WM,Lu MH,Wu C,et al.The adjunctive therapy effect of IABP on the acute myocardial infarction patients with pump failure.Chin.Intervent Cardiol,2003,11(1):16-18.
  • 7魏立,项美香,M.Lins.主动脉内球囊反搏在急性心肌梗死并发心源性休克中的应用[J].中华急诊医学杂志,2002,11(6):389-391. 被引量:17
  • 8刘卫生,刘兵,李成祥,李伟,王海昌.经皮主动脉内球囊反搏术治疗急性心肌梗死并心源性休克26例[J].陕西医学杂志,2003,32(9):837-838. 被引量:6

共引文献5

同被引文献57

  • 1韩雅玲,邓捷,荆全民,王守力,马颖艳,栾波.急性心肌梗死急诊介入治疗无再流发生的独立预测因素及对长期预后的影响[J].中华心血管病杂志,2006,34(6):483-486. 被引量:52
  • 2陈灏珠 李素明.内科学[M]第4版[M].北京:人民卫生出版社,1998.716-734.
  • 3Swallow RA, Agarwala RA, Dawkins KD, et al. Thromboelastography: potential bedside tool to assess the effects of antiplatelet therapy? Platelets 2006( 17):385-392.
  • 4Bakhai A, Collinson J, Flather MD, et al. Diabetic patients with acute coronary syndromes in the UK: high risk and under treated results from the prospective registry of acute ischaemic syndromes in the UK (PRAIS-UK). Int J Cardiol, 2005, 100(1) : 79-84.
  • 5Angiolillo DJ, Bemardo E, Ramirez C, et al. Insulin therapy is associated with platelet dysfunction in patients with type 2 diabetes meIIitus on dual oral antiplatelet treatment. J Am Coil Cardio12006(48):298-304.
  • 6Lev EL,Patel RT,Maresh KJ, et al. Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention: the role of dual drug resistance. J Am Coil Cardiol, 2006(47) :27-33.
  • 7Angiolillo D J, Shoemaker SB, Desai B, et al. Randomized comparison of a high clopidogrel maintenance dose in patients with diabetes menitus and coronary artery disease: results of the Optimizing Antiplatelet Therapy in Diabetes Mellitus (OPTIMUS) study. Circulation 2007 (115):708-716.
  • 8廖晓星,詹红.急诊胸痛患者的识别和诊治流程建议.第十九届长城国际心脏病学会议2008.
  • 9Sjauw KD,Engstrom AE,Vis MM,et al.A Systematic rexiew and meta-analysis of intro-aortic ballon pump therapy in ST-elelavation myocatdial infarction:Eur Heart J,2009,8(30):459-468.
  • 10麦名建.中西医结合抢救急性心肌梗塞(AMI)30年的回顾与展望[A].第三届世界中西医结合大会论文摘要集[C].中国中西医结合学会.2007:493-494.

引证文献8

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部